ACTINIUM PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Revenue
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Increase (Decrease) in Deferred Revenue of -$336.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2024-03-29
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2023-03-31 was -$336.00K.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2022-12-31 was -$91.00K.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for the quarter ending 2022-09-30 was -$113.00K.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in deferred revenue for fiscal 2022 was -$998.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-03-31 | -$336.00K 10-Q · filed 2023-05-15 | -$427.00K derived: sum of 2 quarters · filed 2024-03-29 | -$540.00K derived: sum of 3 quarters · filed 2024-03-29 | ||||
| 2022-12-31 | -$91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$204.00K derived: sum of 2 quarters · filed 2024-03-29 | -$998.00K 10-K · filed 2024-03-29 | $35.00M 10-K · filed 2023-03-31 | |||
| 2022-09-30 | -$113.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$907.00K 10-Q · filed 2023-11-02 | $35.00M 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | -$794.00K 10-Q · filed 2023-08-14 | $35.00M 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |